Login to Your Account

Atlas-backed Avrobio lands $25M series A for ex-vivo gene therapy

By Marie Powers
News Editor

Tuesday, August 2, 2016

After seeding gene therapy start-up Avrobio Inc. earlier this year, Atlas Venture stepped back up to the plate, joined by Clarus and SV Life Sciences, to fund the company’s $25 million series A.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription